Disease history of patients with COPD

BACKGROUND AND AIM: This study aimed to obtain real-life data of patients diagnosed with chronic obstructive pulmonary disease (COPD) at least one year ago, including smoking history, inhaler device training, and the number of exacerbations. METHODS: This study was planned as a nationwide, prospective, observational, multicenter, and noninterventional study, and web-based electronic case forms were used to register the patients. RESULTS: A total of 460 patients from 11 centers were included, of whom 88.3% were males. Of the total patients, 137 (29.8%) were current smokers, and 292 (63.5%) were ex-smokers. One hundred twenty-four (29.6%) patients did not receive inhaler device training. Repeated inhaler device training in the follow-up visits was not performed in 255 (60.8%) patients. Of the total participants, 187 (41.0%) reported no exacerbations in the previous year. The mean number of exacerbations per person over the previous year was 1.19. The annual rates of influenza and pneumococcal vaccines were 34.8% and 4.2%, respectively. CONCLUSIONS: Patients should be trained more efficiently in the risks of COPD, use of inhaler devices, exacerbations, and improving quality of life.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology 2016;21:14–23.
2. Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom 2018;3:e4.
3. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and causespecific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459–544.
4. Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M. The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2016;20:11–23.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988- 1994. Arch Intern Med 2000;160:1683–9.
6. Buist AS, Vollmer WM, McBurnie MA. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008;12:703–8.
7. Suerdem M, Gunen H, Akyildiz L, Cilli A, Ozlu T, Uzaslan E, et al. Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: a real-life study. Int J Chron Obstruct Pulmon Dis 2020;15:261–7.
8. NICE guideline. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Available at: www.nice.org.uk/ guidance/ng115. Accessed Aug 25, 2022.
9. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. Available at: http://www.gold copd.org/. Accessed Aug 25, 2022.
10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26:319–38.
11. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015;5:020415.
12. World Health Organization. Chronic respiratory diseases. Burden of COPD. Available at: http://www.who.int/respiratory/copd/ burden/en/. Accessed Jun 25, 2020.
13. Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med 2014;189:1022–30.
14. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, Pehlivan E. Prevalence of COPD: first epidemiological study of a large region in Turkey. Eur J Intern Med 2008;19:499–504.
15. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418–22.
16. O’Donnell DE, Deesomchok A, Lam YM, Guenette JA, Amornputtisathaporn N, Forkert L, et al. Effects of BMI on static lung volumes in patients with airway obstruction. Chest 2011;140:461–8.
17. Collins BF, Ramenofsky D, Au DH, Ma J, Uman JE, Feemster LC. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest 2014;146:1513–20.
18. Buffels J, Degryse J, Heyrman J, Decramer M; DIDASCO Study. Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. Ches. 2004;125:1394–9.
19. Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009;64:863–8.
20. Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000;55:789–94.
21. Hvidsten SC, Storesund L, Wentzel-Larsen T, Gulsvik A, Lehmann S. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J 2010;4:13–21.
22. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77–121.
23. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52 Suppl 5:S1–28.
24. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest 1998;113:123S–63S.
25. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543–54.
26. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497–505.
27. Aydemir Y. Assessment of the factors affecting the failure to use inhaler devices before and after training. Respir Med 2015;109:451–8.
28. Aydemir Y. Misuse of inhalation devices-effective parameters and the role of education. Solunum 2013;15:32–8.
29. Calışkaner AZ, Oztürk C, Ceylan E, Pekcan S, Yılmaz O, Oztürk S, et al. The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: the INTEDA-1 study. Tuberk Toraks 2013;61:183–92.
30. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000;16:1037–42.
31. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006:CD002733.
32. Walters JA, Smith S, Poole P, Granger RH, Wood-Baker R. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010:CD001390.

APA	Süerdem M, Sarioglu N, Ogan N, Arslan S, Yıldırım G, Erçen Diken Ö, bozkus f, GÜLBAŞ G, Yılmaz Demirci N, Sengul A, H, Kurtipek E (2022). Disease history of patients with COPD. , 206 - 211. 10.14744/ejp.2022.7002
Chicago	Süerdem Mecit,Sarioglu Nurhan,Ogan Nalan,Arslan Sertaç,Yıldırım Gülfem,Erçen Diken Özlem,bozkus fulsen,GÜLBAŞ GAZİ,Yılmaz Demirci Nilgün,Sengul Aysun, Hakan,Kurtipek Ercan Disease history of patients with COPD. (2022): 206 - 211. 10.14744/ejp.2022.7002
MLA	Süerdem Mecit,Sarioglu Nurhan,Ogan Nalan,Arslan Sertaç,Yıldırım Gülfem,Erçen Diken Özlem,bozkus fulsen,GÜLBAŞ GAZİ,Yılmaz Demirci Nilgün,Sengul Aysun, Hakan,Kurtipek Ercan Disease history of patients with COPD. , 2022, ss.206 - 211. 10.14744/ejp.2022.7002
AMA	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E Disease history of patients with COPD. . 2022; 206 - 211. 10.14744/ejp.2022.7002
Vancouver	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E Disease history of patients with COPD. . 2022; 206 - 211. 10.14744/ejp.2022.7002
IEEE	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E "Disease history of patients with COPD." , ss.206 - 211, 2022. 10.14744/ejp.2022.7002
ISNAD	Süerdem, Mecit vd. "Disease history of patients with COPD". (2022), 206-211. https://doi.org/10.14744/ejp.2022.7002

APA	Süerdem M, Sarioglu N, Ogan N, Arslan S, Yıldırım G, Erçen Diken Ö, bozkus f, GÜLBAŞ G, Yılmaz Demirci N, Sengul A, H, Kurtipek E (2022). Disease history of patients with COPD. Eurasian Journal of Pulmonology, 24(3), 206 - 211. 10.14744/ejp.2022.7002
Chicago	Süerdem Mecit,Sarioglu Nurhan,Ogan Nalan,Arslan Sertaç,Yıldırım Gülfem,Erçen Diken Özlem,bozkus fulsen,GÜLBAŞ GAZİ,Yılmaz Demirci Nilgün,Sengul Aysun, Hakan,Kurtipek Ercan Disease history of patients with COPD. Eurasian Journal of Pulmonology 24, no.3 (2022): 206 - 211. 10.14744/ejp.2022.7002
MLA	Süerdem Mecit,Sarioglu Nurhan,Ogan Nalan,Arslan Sertaç,Yıldırım Gülfem,Erçen Diken Özlem,bozkus fulsen,GÜLBAŞ GAZİ,Yılmaz Demirci Nilgün,Sengul Aysun, Hakan,Kurtipek Ercan Disease history of patients with COPD. Eurasian Journal of Pulmonology, vol.24, no.3, 2022, ss.206 - 211. 10.14744/ejp.2022.7002
AMA	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E Disease history of patients with COPD. Eurasian Journal of Pulmonology. 2022; 24(3): 206 - 211. 10.14744/ejp.2022.7002
Vancouver	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E Disease history of patients with COPD. Eurasian Journal of Pulmonology. 2022; 24(3): 206 - 211. 10.14744/ejp.2022.7002
IEEE	Süerdem M,Sarioglu N,Ogan N,Arslan S,Yıldırım G,Erçen Diken Ö,bozkus f,GÜLBAŞ G,Yılmaz Demirci N,Sengul A, H,Kurtipek E "Disease history of patients with COPD." Eurasian Journal of Pulmonology, 24, ss.206 - 211, 2022. 10.14744/ejp.2022.7002
ISNAD	Süerdem, Mecit vd. "Disease history of patients with COPD". Eurasian Journal of Pulmonology 24/3 (2022), 206-211. https://doi.org/10.14744/ejp.2022.7002